The treatment of the patients with metastatic spinal lesions is one of the most difficult problems in modern vertebrology and oncology. The experience of Russian Cancer Research Center based on the clinical analysis on 214 patients with metastatic spine disease showed the results of median survival rate overall 6 months. The mean survival rate in cases of renal cancer metastases consisted 11,2 months, breast cancer - 16,2 months, lung cancer mts - 2,1 months, prostate cancer - 17,7 months, unknown primary origin - 7,8 months. We compared our results with expected survival, scored by Tokuhashi scale. The real survival rate and expected matched only in patients with renal and lung cancer mts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.